Bleeding clinical trials in California
12 studies for Bleeding are looking for participants at sites in California.
Cities in California
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- The Regents of the University of California||UC Davis Health, Rancho Cordova
- UC Davis Health, Sacramento
- UC Davis Ambulatory Care Clinic, Sacramento
- and 3 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT05568719CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
- Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco, San Francisco
RecruitingPhase 2
Ages 18 to 90 · All sexes · Updated Sep 29, 2026 · NCT05958342Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Mission Cardiovascular Research Institute, Fremont
- National Institute of California Heart and Vein Specialists, Huntington Beach
- Profound Research LLC at San Diego Cardiovascular Associates, La Jolla
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Valley Clinical Trials, Inc, Covina
- North Coast Cardiology, Encinitas
- Mission Cardiovascular Research Institute, Fremont
- and 7 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07175428Onyx™ Liquid Embolic IDE Clinical Study
- University of California, Irvine, Irvine
- Stanford Medical Center, Palo Alto
Recruiting
Ages 22 and older · All sexes · Updated Sep 21, 2026 · NCT06742801A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06948318Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404Oxytocin Pharmacokinetics and Pharmacodynamics
- Stanford University, Stanford
RecruitingPhase 2
Ages 18 to 50 · Women · Updated Aug 21, 2026 · NCT05488457A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
- Torrance Memorial, Torrance
RecruitingPhase 3
1 Month · All sexes · Updated Jun 30, 2026 · NCT06664775Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- University of Southern California, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- Stanford University, Stanford
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 26, 2026 · NCT04045665Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
- University of California San Diego, San Diego
- Planned Parenthood of the Pacific Southwest, San Diego
RecruitingPhase 4Healthy volunteers welcome
Ages 18 and older · Women · Updated Jun 15, 2026 · NCT06820177From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.